| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.1M | — | -9.7% |
| SG&A Expense | $1.9M | — | +23.4% |
| Operating Income | -$4.0M | — | -3.6% |
| Pre-tax Income | -$3.8M | — | -4.1% |
| Income Tax | $0 | — | — |
| Net Income | -$3.8M | — | -4.1% |
| EPS (Basic) | -$0.79 | — | -119.4% |
| EPS (Diluted) | -$0.79 | — | -119.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.7M | +33.6% | +22.7% |
| Current Assets | $14.2M | +30.2% | +18.4% |
| Total Assets | $14.4M | +29.4% | +18.6% |
| Current Liabilities | $5.2M | -8.1% | -32.7% |
| Total Liabilities | $5.3M | -8.2% | -31.4% |
| Stockholders' Equity | $9.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.3M | — | +11.6% |
| Financing Cash Flow | $7.7M | — | — |
| +107.1% |